EK, E., MA, B., F, R., MB, S., H, S., A, M., & M, M. (2022). Predicting incomplete cytoreduction in patients with advanced ovarian cancer. Frontiers in oncology, 12, 1060006. https://doi.org/10.3389/fonc.2022.1060006
Chicago Style (17th ed.) CitationEK, Egger, Buchen MA, Recker F, Stope MB, Strunk H, Mustea A, and Marinova M. "Predicting Incomplete Cytoreduction in Patients with Advanced Ovarian Cancer." Frontiers in Oncology 12 (2022): 1060006. https://doi.org/10.3389/fonc.2022.1060006.
MLA (9th ed.) CitationEK, Egger, et al. "Predicting Incomplete Cytoreduction in Patients with Advanced Ovarian Cancer." Frontiers in Oncology, vol. 12, 2022, p. 1060006, https://doi.org/10.3389/fonc.2022.1060006.
Warning: These citations may not always be 100% accurate.